Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 28 Feb 2008):

Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys.

Full Abstract

In monkeys, elevating ambient temperature has been shown to increase sensitivity to 3,4-methylenedioxymethamphetamine (MDMA) reinforcement. Earlier rodent studies have shown that elevations in thyroid levels (hyperthyroidism) parallel changes in elevating the ambient temperature on MDMA-induced thermogenesis, but the interaction has not been examined in monkeys. This study was designed to evaluate the effects of chronic levothyroxine (3.0 or 4.5 microg/kg/day, intramuscularly; Levo) treatment on MDMA-induced increases in body temperature following 1.5 mg/kg (intravenously) MDMA and self-administration when MDMA (0.03-0.3 mg/kg/injection) and food were available under a concurrent fixed-ratio 30 schedule of reinforcement in rhesus monkeys (n=4). Earlier studies had shown that 1.5 mg/kg MDMA did not affect thermoregulation at 24 degrees C. Chronic Levo treatment resulted in significant increases in MDMA-induced thermogenesis. In the self-administration experiment, MDMA choice increased with dose, such that food was preferred over saline and a low MDMA dose (0.03 mg/kg/injection), whereas 0.1 and 0.3 mg/kg/injection MDMA was preferred over food. Although elevating ambient temperature had been shown to increase MDMA potency, there was no effect of chronic Levo treatment on MDMA choice. These results suggest that changes in thyroxine levels do not parallel the changes in ambient temperature in altering the reinforcing strength of MDMA.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Banks, Matthew L (ML); Czoty, Paul W (PW); Sprague, Jon E (JE); Nader, Michael A (MA);

Affiliation: Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1083, USA.

Grants: DA-020281 (Agency:United States NIDA) ; DA-06634 (Agency:United States NIDA)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal: Behavioural pharmacology (Behav Pharmacol), published in England. (Language: eng)

Reference: 2008-Mar; vol 19 (issue 2) : pp 167-70

Dates: Created 2008/03/11; Completed 2008/06/17;

PMID: 18332682, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Hallucinogens (0) ; N-Methyl-3,4-methylenedioxyamphetamine (42542-10-9) ; Thyroxine (7488-70-2)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/6/2004
11/17/2007
Higher Relevance Score (377/1000)
Lower Relevance Score (268/1000)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index